HIV / AIDS
Oct 2, 2024
The HIV Impact Network for Vertical Transmission Elimination (HIVE) is a multi-country knowledge-exchange network. HIVE collaborates with ministries of health and partner organizations in the vertical transmission prevention response, including networks of people...
Sep 27, 2024
This project focuses on supporting data quality assessment (DQA) of interruption in treatment and viral load coverage at selected high-volume sites. Through the DQA, the Servicio Nacional de Salud (SNS) and implementing partners will develop line lists of patients...
Sep 17, 2024
A Phase 2, open-label, multicenter, randomized study to evaluate lenacapavir, a medication given as twice-yearly long-acting shots versus standard daily oral pills (tenofovir/emtricitabine) for prevention of HIV among people who are at risk for HIV via injection drug...
Sep 17, 2024
A Phase 2, open-label, multicenter, randomized study to evaluate   lenacapavir, a medication given as twice-yearly long-acting shots versus the standard oral medication (tenofovir/emtricitabine) used for prevention of HIV in cisgender women in the United States. The...
Sep 17, 2024
A Phase 2, open-label, multicenter, randomized study to evaluate the pharmacokinetics, safety, and acceptability of twice-yearly long-acting subcutaneous lenacapavir for pre-exposure prophylaxis in cisgender women in the United...
